![AB0436 Persistence of Clinical Remission by a Decreased Treatment Regimen of 4 MG/KG Intravenous Tocilizumab: A Randomized Clinical Trial]()
AB0436 Persistence of Clinical Remission by a Decreased Treatment Regimen of 4 MG/KG Intravenous Tocilizumab: A Randomized Clinical TrialGiollo, A.; Viapiana, O.; Orsolini, G.; Liuzza, S.; Troplini, S.; Risoli, M.; Dal Forno, I.; Idolazzi, L.; Gatti, D.; Rossini, M.; Adami, S. · Annals of the Rheumatic Diseases · 2015